Becton Dickinson (BDX) Non-Current Assets (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Non-Current Assets of $42.8 billion for Q1 2026, down 6.51% year-over-year from $45.8 billion in Q1 2025, and down 6.2% quarter-over-quarter from $45.7 billion in Q4 2025.
Becton Dickinson (BDX) Non-Current Assets (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Non-Current Assets for 18 consecutive years, with $42.8 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 6.51% year-over-year to $42.8 billion; the TTM figure through Mar 2026 stood at $180.4 billion (down 0.85% YoY), while the FY2025 annual figure was $46.1 billion, down 1.6% from the prior year.
- Non-Current Assets fell to $42.8 billion in Q1 2026 per BDX's latest filing, from $45.7 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $46.8 billion in Q3 2024 and bottomed at $42.8 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $44.8 billion across 5 years, with a median of $44.8 billion in 2022.
- Annual changes were most pronounced in 2024 — Non-Current Assets gained 6.15% — and 2026, when it retreated 6.51%.
- Becton Dickinson's Non-Current Assets stood at $45.0 billion in 2022, then fell by 1.86% to $44.1 billion in 2023, then rose by 4.28% to $46.0 billion in 2024, then decreased by 0.77% to $45.7 billion in 2025, then slipped by 6.2% to $42.8 billion in 2026.
- Business Quant data shows BDX's Non-Current Assets at $42.8 billion in Q1 2026, $45.7 billion in Q4 2025, and $46.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 3.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.59 Bn |
| Mar 31, 2026 | 42.82 Bn |
| Dec 31, 2025 | 45.65 Bn |
| Sep 30, 2025 | 46.07 Bn |
| Jun 30, 2025 | 45.91 Bn |
| Mar 31, 2025 | 45.80 Bn |
| Dec 31, 2024 | 46.01 Bn |
| Sep 30, 2024 | 46.82 Bn |
| Jun 30, 2024 | 43.38 Bn |
| Mar 31, 2024 | 43.82 Bn |
| Dec 31, 2023 | 44.12 Bn |
| Sep 30, 2023 | 44.10 Bn |
| Jun 30, 2023 | 44.43 Bn |
| Mar 31, 2023 | 44.81 Bn |
| Dec 31, 2022 | 44.95 Bn |
| Sep 30, 2022 | 44.79 Bn |
| Jun 30, 2022 | 43.65 Bn |
| Mar 31, 2022 | 44.63 Bn |
| Dec 31, 2021 | 45.06 Bn |
| Sep 30, 2021 | 45.03 Bn |